HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria

被引：0
|
作者：
Qi Sun
Qi Li
Fuping Gao
Hongyan Wu
Yao Fu
Jun Yang
Xiangshan Fan
Xiaobin Cui
Xiaohong Pu
机构：
[1] Nanjing Drum Tower Hospital,Department of Pathology
[2] The Affiliated Hospital of Nanjing University Medical School,Center for Digestive Medicine
[3] Nanjing Drum Tower Hospital,Department of Pathology
[4] The Affiliated Hospital of Nanjing University Medical School,undefined
[5] Gaochun People’s Hospital,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Colorectal carcinomas; HER2; Fluorescence in situ hybridization; Immunohistochemistry;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：579 / 592
页数：13
相关论文
共 50 条
  • [41] Comparison of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for the evaluation of HER2/neu in breast cancer.
    Jacobs, TW
    Barnes, MJ
    Yaziji, H
    Gown, AM
    Schnitt, SJ
    LABORATORY INVESTIGATION, 1999, 79 (01) : 23A - 23A
  • [42] Comparison of fluorescence in situ hybridization and dual colour chromogenic in situ hybridization for the assessment of HER2 status on gastric cancer biopsies
    Gomez-Martin, C.
    Garcia-Garcia, E.
    Suarez-Gauthier, A.
    Conde, E.
    Lopez-Rios, F.
    EJC SUPPLEMENTS, 2009, 7 (02): : 404 - 404
  • [43] Comparison of dual-color in-situ hybridization and fluorescence in-situ hybridization in HER2 gene amplification in breast cancer
    Horii, Rie
    Matsuura, Masaaki
    Iwase, Takuji
    Ito, Yoshinori
    Akiyama, Futoshi
    BREAST CANCER, 2014, 21 (05) : 598 - 604
  • [44] A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancer
    Bahreini, Fatemeh
    Soltanian, Ali Reza
    Mehdipour, Parvin
    BREAST CANCER, 2015, 22 (06) : 615 - 625
  • [45] A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancer
    Fatemeh Bahreini
    Ali Reza Soltanian
    Parvin Mehdipour
    Breast Cancer, 2015, 22 : 615 - 625
  • [46] Comparison of dual-color in-situ hybridization and fluorescence in-situ hybridization in HER2 gene amplification in breast cancer
    Rie Horii
    Masaaki Matsuura
    Takuji Iwase
    Yoshinori Ito
    Futoshi Akiyama
    Breast Cancer, 2014, 21 : 598 - 604
  • [47] Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues
    Falk Zakrzewski
    Walter de Back
    Martin Weigert
    Torsten Wenke
    Silke Zeugner
    Robert Mantey
    Christian Sperling
    Katrin Friedrich
    Ingo Roeder
    Daniela Aust
    Gustavo Baretton
    Pia Hönscheid
    Scientific Reports, 9
  • [48] Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues
    Zakrzewski, Falk
    de Back, Walter
    Weigert, Martin
    Wenke, Torsten
    Zeugner, Silke
    Mantey, Robert
    Sperling, Christian
    Friedrich, Katrin
    Roeder, Ingo
    Aust, Daniela
    Baretton, Gustavo
    Hoenscheid, Pia
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [49] HER2 Status in Gastric Adenocarcinomas Assessed by Immunohistochemistry, Automated Silver-Enhanced In Situ Hybridization and Fluorescence In Situ Hybridization
    Kim, Aeri
    Bae, Jung Min
    Kim, Se Won
    Gu, Mi Jin
    Bae, Young Kyung
    KOREAN JOURNAL OF PATHOLOGY, 2010, 44 (05) : 493 - 501
  • [50] HER2 Amplification in Gastroesophageal Adenocarcinoma Correlation of Two Antibodies Using Gastric Cancer Scoring Criteria, H Score, and Digital Image Analysis With Fluorescence In Situ Hybridization
    Radu, Oana M.
    Foxwell, Tyler
    Cieply, Kathleen
    Navina, Sarah
    Dacic, Sanja
    Nason, Katie S.
    Davison, Jon M.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (04) : 583 - 594
12345